In the News

199 News Items found
Detail of an MSK scientist working in a lab
MSK Research Highlights, October 31, 2023
New MSK research identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic differences in tumors from patients with African ancestry; and finds a virtual mind-body fitness program reduced hospitalizations for those in active cancer treatment. A clinical trial led by MSK also resulted in the approval of a new combination therapy for non-small cell lung cancer.
detail shot of a lab coat with the MSK logo
MSK Research Highlights, June 18, 2025
New MSK research finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is linked to APOBEC3 enzymes; investigates opportunities for restoring sensitivity to endocrine therapy; and finds acupuncture may help prostate cancer survivors wake up less often at night to urinate.
Finding
New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer.
Blue cells on a black background
In the Lab
Scientists at Memorial Sloan Kettering have created a model of rectal cancer using human-tumor-derived organoids.
Kenneth Offit
In the Clinic
MSK’s new Robert and Kate Niehaus Center for Inherited Cancer Genomics is using the latest in gene sequencing technologies to discover the inherited causes of cancer.
Image of As, Ts, Cs, and Gs representing genetic code
Announcement
Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.
Seth Frankel sitting in a red chair
it means to survive cancer and learn how MSK is honoring all cancer survivors this year during National Cancer Survivor Month.
Close-up photo of someone walking on the road
Support
Learn why some patients are less physically active during and after treatment — plus, some tips from Jun Mao, Chief of the Integrative Medicine Service at MSK.
a lab coat hangs in an MSK lab
New MSK research discovers a new approach that could prevent chemotherapy-related leukemia; shows how monoclonal antibodies can turn neutrophils into cancer killers; helps develop sensitive CAR T cells that target CD70 antigen to destroy cancer cells; and uses single-cell studies to yield new clues about a rare, aggressive pediatric sarcoma.
Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings provide a novel framework for thinking about metastasis and how to treat it.